Skip to search formSkip to main contentSkip to account menu

Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine

Known as: Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Etoposide Regimen, CHOPE regimen, VAC0P 
An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma. It includes the drugs cyclophosphamide, doxorubicin… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Self-replicating gene drives that modify sex ratios or infer a fitness cost could be used to control populations of invasive… 
2016
2016
Objectives: Optimal chemotherapy regimen for peripheral T-cell lymphomas (PTCL) has not been fully defined. This study aimed to… 
Review
2015
Review
2015
AbstractAs normal healthy skeletal muscle does not contain lymphoid tissue, extra nodal lymphoma involving multiple muscles is… 
2014
2014
We herein report the case of a 50-year-old woman who presented with persistent fever and a large mass in her right breast… 
2001
2001
To address the feasibility and outcome of moderate dose intensification with granulocyte‐colony stimulating factor (G‐CSF) for… 
2001
2001
Successful treatment of advanced-stage Hodgkin's disease (HD) may critically depend on dose intensity. Because mechlorethamine… 
2000
2000
Summary Background Patients with resistant diffuse aggressive non-Hodgkin's lymphoma (DA-NHL) have a poor prognosis. Studies have…